Life Sciences tax services
We have created a network of tax advisors who understand the complex realities of the life sciences marketplace. Our Life Sciences tax services cover the breadth of advisory and compliance services for both corporate and personal tax clients.
We provide corporate and "business connected" individual tax advisory and reporting services throughout every stage of the tax life cycle: planning, accounting, compliance and controversy.
We offer tax advisory and compliance services to companies and their international or domestic assignees. Our offerings cover identification and mitigation of employment-related risks.
These services include:
- Global mobility advisory
- Assignment administration
- Process risk assessments
- Business immigration
- Expatriate tax return processing
We also advise clients on global talent management, performance and reward programs.
We focus on advisory and compliance services for all aspects and types of indirect tax, including value added tax (VAT), goods and services tax, customs duties and environmental levies.
Indirect taxes affect the supply chain and the financial system and pose a unique challenge to multi-national tax functions, since they must be managed accurately and in real time.
We provide corporate income tax advice on cross-border financing and structuring, planning, risk management, transfer pricing and tax-efficient supply chain management.
We focus on the tax implications of transactions from due diligence through post-deal implementation, to mitigate risk and enhance opportunity. We can suggest structuring alternatives to balance investor sensitivities, promote exit readiness and raise opportunities for improved returns.
EY's Virginie Lefebvre-Dutilleul tells us about how EY's legal credentials can add value to our work with life sciences clients. Services described in video cannot be provided by member firms in certain jurisdictions such as the United States.
Connect with us
Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.
Globalization of the pharmaceutical industry and increased outsourcing have drastically changed the R&D landscape. This report explores the impact on R&D tax incentives.